• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化性心肌病:直击问题核心

Cirrhotic cardiomyopathy: getting to the heart of the matter.

作者信息

Ma Z, Lee S S

机构信息

Liver Unit, Gastroenterology Research Group, University of Calgary, Alberta, Canada.

出版信息

Hepatology. 1996 Aug;24(2):451-9. doi: 10.1002/hep.510240226.

DOI:10.1002/hep.510240226
PMID:8690419
Abstract

In cirrhosis, cardiac contractile function has been extensively documented to be abnormal. At baseline, cardiac output is increased, and this is one of the characteristics of hyperdynamic circulation. However, when cirrhotic patients are challenged by pharmacological or physiological stress, ventricular hyporesponsiveness is revealed. Similar patterns have been noted in cirrhotic animal models. This phenomenon has been termed "cirrhotic cardiomyopathy." Although alcohol abuse may contribute to some cases of cirrhotic cardiomyopathy, it has been clearly documented to occur even in the absence of alcohol ingestion. Diminished myocardial beta-adrenergic receptor signal transduction function, possibly caused by a persistent elevation in norepinephrine content, has been shown to play an important role. Alternation in cardiac plasma membrane properties due to impaired lipid metabolism is also crucial. Other possible pathogenic factors are reviewed, including accumulation of cardiodepressant substances caused by hepatocellular insufficiency, and ventricular overload secondary to increased blood volume and hyperdynamic circulation. Because the cardiac reserve function is borderline in patients with cirrhosis, cardiovascular status should be carefully monitored, especially when patients undergo stresses such as liver transplantation or portosystemic shunting procedures.

摘要

在肝硬化患者中,心脏收缩功能异常已有大量文献记载。在基线状态下,心输出量增加,这是高动力循环的特征之一。然而,当肝硬化患者受到药物或生理应激挑战时,会出现心室反应性降低。在肝硬化动物模型中也观察到类似模式。这种现象被称为“肝硬化性心肌病”。虽然酒精滥用可能导致部分肝硬化性心肌病病例,但即使在无酒精摄入的情况下也明确有该疾病发生。已表明,去甲肾上腺素含量持续升高可能导致心肌β - 肾上腺素能受体信号转导功能减弱,这起了重要作用。脂质代谢受损导致心脏质膜特性改变也很关键。还综述了其他可能的致病因素,包括肝细胞功能不全导致的心脏抑制物质蓄积,以及血容量增加和高动力循环继发的心室负荷过重。由于肝硬化患者的心脏储备功能处于临界状态,应仔细监测心血管状况,尤其是在患者接受肝移植或门体分流手术等应激情况时。

相似文献

1
Cirrhotic cardiomyopathy: getting to the heart of the matter.肝硬化性心肌病:直击问题核心
Hepatology. 1996 Aug;24(2):451-9. doi: 10.1002/hep.510240226.
2
Cirrhotic cardiomyopathy.肝硬化性心肌病
Semin Liver Dis. 2008 Feb;28(1):59-69. doi: 10.1055/s-2008-1040321.
3
[Cirrhotic cardiomyopathy].[肝硬化性心肌病]
Korean J Hepatol. 2007 Mar;13(1):20-6.
4
Cardiac dysfunction in cirrhosis.肝硬化中的心脏功能障碍。
Best Pract Res Clin Gastroenterol. 2007;21(1):125-40. doi: 10.1016/j.bpg.2006.06.003.
5
Therapy insight: Cirrhotic cardiomyopathy.治疗洞察:肝硬化性心肌病。
Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):329-37. doi: 10.1038/ncpgasthep0498.
6
Cirrhotic cardiomyopathy.肝硬化性心肌病
Dig Liver Dis. 2007 Jun;39(6):507-15. doi: 10.1016/j.dld.2006.12.014. Epub 2007 Mar 23.
7
[Cirrhotic cardiomyopathy].[肝硬化性心肌病]
Rev Med Suisse. 2009 Sep 2;5(215):1725-6, 1728, 1730-1.
8
Cirrhotic cardiomyopathy.肝硬化性心肌病。
J Hepatol. 2010 Jul;53(1):179-90. doi: 10.1016/j.jhep.2010.02.023. Epub 2010 Mar 31.
9
Cirrhotic cardiomyopathy.肝硬化性心肌病
World J Gastroenterol. 2015 Nov 7;21(41):11502-21. doi: 10.3748/wjg.v21.i41.11502.
10
[Cardiomyopathy in liver cirrhosis--an undiagnosed entity?].[肝硬化中的心肌病——一种未被诊断的病症?]
Rev Med Chir Soc Med Nat Iasi. 2010 Apr-Jun;114(2):319-26.

引用本文的文献

1
Hepato-Renal Crosstalk in Acute and Chronic Disease: From Shared Pathways to Therapeutic Targets.急慢性疾病中的肝肾相互作用:从共同通路到治疗靶点
Biomedicines. 2025 Jul 1;13(7):1618. doi: 10.3390/biomedicines13071618.
2
Decoding the Liver-Heart Axis in Cardiometabolic Diseases.解读心脏代谢疾病中的肝心轴
Circ Res. 2025 May 23;136(11):1335-1362. doi: 10.1161/CIRCRESAHA.125.325492. Epub 2025 May 22.
3
Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies.
移植前肝硬化患者的心脏重塑与心律失常负担:病理生理机制与管理策略
Biomedicines. 2025 Mar 28;13(4):812. doi: 10.3390/biomedicines13040812.
4
LTSI Consensus Guidelines: Preoperative Cardiac Evaluation in Adult Liver Transplant Recipients.LTSI 共识指南:成人肝移植受者的术前心脏评估
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102419. doi: 10.1016/j.jceh.2024.102419. Epub 2024 Oct 18.
5
Continuous Non-Invasive Hemodynamic Monitoring in Cirrhotic Patients-Friend or Foe?肝硬化患者的连续无创血流动力学监测——是福是祸?
Medicina (Kaunas). 2025 Mar 19;61(3):536. doi: 10.3390/medicina61030536.
6
History of the liver-heart relationship.肝心关系的历史。
Clin Liver Dis (Hoboken). 2024 Apr 26;23(1):e0151. doi: 10.1097/CLD.0000000000000151. eCollection 2024 Jan-Jun.
7
The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy.斑点追踪超声心动图在肝硬化性心肌病中的当代作用
Life (Basel). 2024 Jan 25;14(2):179. doi: 10.3390/life14020179.
8
Study of Cardiac Dysfunction in Portal Hypertension: A Single-Center Experience From Eastern India.门静脉高压症中心脏功能障碍的研究:来自印度东部的单中心经验
Cureus. 2023 Dec 28;15(12):e51259. doi: 10.7759/cureus.51259. eCollection 2023 Dec.
9
Alcohol and Heart Failure.酒精与心力衰竭
Eur Cardiol. 2023 Dec 26;18:e65. doi: 10.15420/ecr.2023.12. eCollection 2023.
10
Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy.半乳糖凝集素在包括肝硬化性心肌病在内的心血管疾病中的作用
Pharmaceuticals (Basel). 2023 Jul 7;16(7):978. doi: 10.3390/ph16070978.